Scribe Therapeutics Inc. (SCTX)

NASDAQ: SCTX · Real-Time Price · USD

28.05

-4.95 (-15.00%)

At close: Sep 21, 2026, 4:00 PM EDT

28.90

+0.85 (3.03%)

Pre-market: Sep 22, 2026, 6:00 AM EDT

Scribe Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	35.59	12.8	12.6
Short-Term Investments	7.42	45.17	92.57
Cash & Short-Term Investments	43.01	57.96	105.17
Cash Growth	-	-44.89%	-
Accounts Receivable	1.11	7.09	3.12
Other Receivables	0.12	0.26	0.4
Receivables	1.23	7.35	3.52
Prepaid Expenses	0.87	1.62	1.69
Total Current Assets	45.11	66.93	110.37
Property, Plant & Equipment	8.54	10.07	13.18
Long-Term Deferred Charges	-	0.5	3.6
Other Long-Term Assets	4.29	0.71	0.82
Total Assets	57.93	78.22	127.97

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	2.77	4.57	3.79
Accrued Expenses	7.4	6.71	5.98
Current Portion of Long-Term Debt	37.8	35.34	-
Current Portion of Leases	1.37	1.29	1.12
Current Income Taxes Payable	0.09	-	0.64
Current Unearned Revenue	27.48	21.09	23.41
Other Current Liabilities	1.79	0.07	0.09
Total Current Liabilities	78.7	69.06	35.02
Long-Term Debt	-	-	34.47
Long-Term Leases	4.1	4.8	6.09
Long-Term Unearned Revenue	11.7	19.94	49.01
Other Long-Term Liabilities	7.92	7.49	8.88
Total Liabilities	102.42	101.28	133.47

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Common Stock	0.01	0.01	0.01
Additional Paid-In Capital	16.67	14.24	9.95
Retained Earnings	-181.53	-157.71	-135.9
Comprehensive Income & Other	-0	0.04	0.07
Total Common Equity	-164.85	-143.42	-125.86
Shareholders' Equity	-44.49	-23.06	-5.5
Total Liabilities & Equity	57.93	78.22	127.97

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Total Debt	43.27	41.43	41.68
Net Cash (Debt)	-0.26	16.54	63.49
Net Cash Growth	-	-73.96%	-
Net Cash Per Share	-0.11	6.81	26.50
Filing Date Shares Outstanding	18.93	2.45	2.42
Total Common Shares Outstanding	2.49	2.45	2.42
Working Capital	-33.59	-2.12	75.36
Book Value Per Share	-66.33	-58.51	-52.06
Tangible Book Value	-164.85	-143.42	-125.86
Tangible Book Value Per Share	-66.33	-58.51	-52.06
Machinery	13	12.82	12.39
Leasehold Improvements	4.94	4.94	4.94

SEC Filings: 10-K · 10-Q